이 사이트는 당사의 설명에 따라 쿠키를 사용합니다. 쿠키 정책. 우리가 제공하는 쿠키를 보려면 다음을 확인하십시오. 쿠키 설정 패널. 이 쿠키 정책에 동의합니다. 이 메시지를 다시 표시하지 않습니다.

Event on

Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease

프레젠테이션

  • PROF. GOTTFRIED RUDOFSKY

    PROF. GOTTFRIED RUDOFSKY
    (SWITZERLAND)
    Speaker

    Specialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland

제시된 견해와 의견은 저자의 것입니다. 이 웹캐스트에 포함된 콘텐츠는 정보 제공/교육 목적으로만 사용됩니다.

Background

Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether1 — which is why testing in at-risk groups is so important.

Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it valtogether.

Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Series of six livestream events covering:

  • Importance of regular testing for early detection and monitoring in high-risk patients
  • Importance of ACR testing beside the determination of eGFR
  • Latest guidance on disease prevention and management
  • Case studies
Share
Like
Tweet
References
  1. Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
  2. The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease.%20Accessed%201.%20September%202022 https://www.worldkidneyday.org/facts/chronic-kidney-disease. Accessed 1. September 2022

© 2023 애보트. 판권 소유. 참조된 모든 상표는 Abbott 그룹 회사 또는 해당 소유자의 상표입니다. COL-00000

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"ko","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"ko","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/ko/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"ko","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/ko/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/ko/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Bugsnag Called"